Search

Your search keyword '"PATENT law"' showing total 414 results

Search Constraints

Start Over You searched for: Descriptor "PATENT law" Remove constraint Descriptor: "PATENT law" Region europe Remove constraint Region: europe
414 results on '"PATENT law"'

Search Results

1. The Untapped Potential of Patent Law in Deterring Environmentally Unsustainable Innovation.

2. Redefining Patent Translation: The Influence of ChatGPT and the Urgency to Align Patent Language Regimes in Europe with Progress in Translation Technology.

3. Predicaments during a period of health emergency: Waiving patent protections or innovative public procurement? The example of advance purchase agreements (APA) for COVID-19 vaccines.

4. Patents, Governance and Control: Ethics and the Patentability of Novel Beings and Advanced Biotechnologies in Europe.

5. IS THE USPTO TURNING ALICE INTO EPC ARTICLE 52?

6. The quality factor in patent systems.

7. Patentability and de-extinct animals in Europe: the patented woolly mammoth?

8. Patent Law and Innovation in Europe during the Industrial Revolution.

9. Pharmaceutical pricing conundrum: time to get rid of it?

10. Ways Out of the Patenting Prohibition? Human Parthenogenetic and Induced Pluripotent Stem Cells.

11. Understanding the Transitional Provisions of the Agreement on the Unified Patent Court.

12. Update on the Unitary Patent Court and the European Patent with Unitary Effect.

13. Exclusion of Patentability of Embryonic Stem Cells in Europe: Another Restriction by the European Patent Office.

14. Auteurswhat? Dutch Copyright Law not Tolerated by the CJEU: ACI Adam BV v Stichting de Thuiskople and Stichting Onderhandelingen Thuiskopie vergoeding (C-435/12).

15. UNITARY PATENT PROTECTION IN EUROPE-AN ATTUNEMENT ON THE UPCOMING NEW SYSTEM.

16. The Unitary Patent and the Biotechnology Directive: Is Uniform Protection of Biotechnological Inventions Ensured?

17. Pluralism, Principles and Proportionality in Intellectual Property†.

18. Heartbroken By Performer’s Rights Damages Inquiry: Jodie Aysha Henderson v All Around The World Recordings Ltd.

19. PASSING OFF ÎN PRIVINȚA DENUMIRII DE BREVET EUROPEAN CU EFECT UNITAR.

20. ANALIZA I STRUKTURA ZŁOŻONYCH WNIOSKÓW PATENTOWYCH W PROCESIE BUDOWY INNOWACYJNEJ GOSPODARKI W EUROPIE I NA ŚWIECIE.

21. Not fully harmonized: Differences in biotechnology patenting between Europe and the United States.

22. Enforcing a Unitary Patent in Europe: What the U.S. Federal Courts and Community Design Courts Teach Us.

23. Morality: An Equivocal Area in the Patent System.

24. High-Quality Patents for Emerging Science and Technology Through External Actors.

25. Periods and Remedies Under the EPC: Compliance of the EPC with the PLT: Part 1 — Extension of Periods and Further Processing.

26. PATENTNA ZAŠTITA U EU - DA LI JE UJEDINJENJE TRŽIŠTA BLIZU.

27. The Ramifications of the Advocate General's Opinion in the Oliver Brüstle Case.

28. The European Union Patent System: Off Course or On the Rocks?

29. Do public research organisations own most patents invented by their staff?

30. THE PATENTABILITY OF HUMAN EMBRYONIC STEM CELLS: IS THE CONSISTENT APPLICATION OF THE EUROPEAN UNION BIOTECHNOLOGY DIRECTIVE'S MORAL EXCLUSION CLAUSE UNDERMINING INVESTOR CONFIDENCE IN EUROPE, PROVIDING A COMPETITIVE ADVANTAGE TO THE UNITED STATES?

31. THE CONFLUENCE OF EUROPEAN ACTIVISM AND AMERICAN MINIMALISM: "PATENTABLE SUBJECT MATTER" AFTER BILSKI.

32. The Court of Appeal Gives Indirect Infringement of Patents a Broad Interpretation.

33. Patenting Computer-related Inventions in the US and in Europe: The Need for Domestic and International Legal Harmony.

34. ECONOMIC AND LEGAL ASPECTS OF THE PATENT LITIGATION IN THE EUROPEAN UNION: DEVELOPMENTS AND PERSPECTIVES.

35. Towards a Pro-active Approach Concerning the Intersections between the Jordan Patents of Invention Law, United States Patent Law and European Patent Convention.

36. Patent laws and research exemption imperatives -- do scientists have enough freedom to operate?

37. TRADITIONAL KNOWLEDGE AND PATENT PROTECTION: CONFLICTING VIEWS ON INTERNATIONAL PATENT STANDARDS.

38. THE EUROPEAN PATENT SYSTEM: AN OVERVIEW AND CRITIQUE.

39. European case law report.

40. The London Agreement and the cost of patenting in Europe.

41. ONE STEP BEYOND? FROM SODEMARE TO DOCMORRIS: THE EU'S FREEDOM OF ESTABLISHMENT CASE LAW CONCERNING HEALTHCARE.

42. Patenting human pluripotent cells: balancing commercial, academic and ethical interests.

43. Patent analyses in the changed legal regime of the US Patent Law since 2001

44. IN RE KUBIN'S REINVIGORATED NONOBVIOUSNESS STANDARD FOR DNA PATENTS.

45. Why Challenge the Ivory Tower? New Evidence on the Basicness of Academic Patents*.

46. Why Challenge the Ivory Tower? New Evidence on the Basicness of Academic Patents*.

47. Governing the patent system in Europe: the EPO's supranational autonomy and its need for a regulatory perspective.

48. Getting patent policy right: a conclusion to a special issue on the European patent system.

49. Patent reform in Europe and the US.

50. Increasing access to patented inventions by post-grant measures.

Catalog

Books, media, physical & digital resources